218 related articles for article (PubMed ID: 6717737)
1. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
[TBL] [Abstract][Full Text] [Related]
2. [Histological changes and operative findings of pituitary adenomas after bromocriptine treatment].
Takahashi T; Kuwayama A; Katoh T; Kageyama N
Nihon Naibunpi Gakkai Zasshi; 1986 Dec; 62(12):1336-51. PubMed ID: 3817228
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine therapy as pre-operative adjunct of non-functional pituitary macroadenomas.
Zárate A; Morán C; Klériga E; Loyo M; González-Angulo A; Aquilar-Parada E
Acta Endocrinol (Copenh); 1985 Apr; 108(4):445-50. PubMed ID: 3993311
[TBL] [Abstract][Full Text] [Related]
5. [Pathological changes of prolactinomas treated with bromocriptine].
Teramoto A; Takakura K; Fukushima T; Osamura Y
No Shinkei Geka; 1982 Jun; 10(6):619-27. PubMed ID: 7121729
[TBL] [Abstract][Full Text] [Related]
6. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
Esiri MM; Bevan JS; Burke CW; Adams CB
J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas.
Verde G; Oppizzi G; Chiodini PG; Dallabonzana D; Luccarelli G; Liuzzi A
J Endocrinol Invest; 1985 Apr; 8(2):113-5. PubMed ID: 4031376
[TBL] [Abstract][Full Text] [Related]
8. Reduction in size of a pituitary tumor by bromocriptine therapy.
McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
[No Abstract] [Full Text] [Related]
9. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine therapy for non-functioning pituitary adenoma.
van Schaardenburg D; Roelfsema F; van Seters AP; Vielvoye GJ
Clin Endocrinol (Oxf); 1989 May; 30(5):475-84. PubMed ID: 2605786
[TBL] [Abstract][Full Text] [Related]
11. Cytosuppressive effect of bromocriptine on human prolactinomas: stereological analysis of ultrastructural alterations with special reference to secretory granules.
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Cancer Res; 1986 Mar; 46(3):1507-12. PubMed ID: 3943108
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
[TBL] [Abstract][Full Text] [Related]
13. Structural changes in human pituitary tumor after bromocriptine therapy.
Rengachary SS; Tomita T; Jefferies BF; Watanabe I
Neurosurgery; 1982 Feb; 10(2):242-51. PubMed ID: 7070622
[TBL] [Abstract][Full Text] [Related]
14. Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. Case report.
Alhajje A; Lambert M; Crabbé J
J Neurosurg; 1985 Aug; 63(2):288-92. PubMed ID: 4020451
[TBL] [Abstract][Full Text] [Related]
15. [Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine].
Yamashita M; Hirakawa T; Tashiro Y; Matsuda T; Kibe M; Fukushima T; Tomonaga M
No Shinkei Geka; 1987 Jan; 15(1):65-72. PubMed ID: 3822068
[TBL] [Abstract][Full Text] [Related]
16. Assessment by computed tomography of the response of pituitary macroadenomas to bromocriptine.
Chakera TM; Khangure MS; Pullen P
Clin Radiol; 1985 May; 36(3):223-6. PubMed ID: 4064503
[TBL] [Abstract][Full Text] [Related]
17. Bromocriptine reduction of prolactinoma size.
Corenblum B; Hanley DA
Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
Abs R; Parizel PM; Beckers A
J Endocrinol Invest; 1991 Feb; 14(2):135-8. PubMed ID: 1905737
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study.
Bassetti M; Spada A; Pezzo G; Giannattasio G
J Clin Endocrinol Metab; 1984 Feb; 58(2):268-73. PubMed ID: 6693536
[TBL] [Abstract][Full Text] [Related]
20. Perivascular fibrosis in prolactinomas: is it increased by bromocriptine?
Landolt AM; Osterwalder V
J Clin Endocrinol Metab; 1984 Jun; 58(6):1179-83. PubMed ID: 6725514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
